HB 1884 - DIGEST

Provides that a pharmaceutical manufacturing company shall not claim credit under RCW 82.04.4452 if: (1) The company has reduced sales to retail pharmacies in Canada within the twelve months prior to the effective date of this act or at any time after the effective date of this act, pursuant to a company policy issued in response to the direct and indirect sales of company products to residents of the United States by retail pharmacies in Canada; or

(2) The average retail price of the company's products in the United States exceeds the average retail price of the company's products in Canada by at least ten percent, for the twelve months prior to the effective date of this act or for any three-month period after the effective date of this act. A pharmaceutical manufacturing company shall submit an affidavit, as part of the annual survey under this act, stating that the company is not disqualified from the credit under this act.